327869 Supercooling: A Viable Non-Freezing Preservation Method of Hepatocytes

Wednesday, November 6, 2013
Grand Ballroom B (Hilton)
O. Berk Usta1, Yeonhee Kim1, Sinan Ozer1, Bote Bruinsma1, Jungwoo Lee1, Esin Demir2, Tim Berendsen1, Catheleyne Puts1, Maria-Louisa Izamis1, Korkut Uygun1, Basak Uygun1 and Martin L. Yarmush1, (1)Center for Engineering in Medicine (CEM) at Massachusetts General Hospital – Harvard Medical School - Shriners Hospital for Children, Boston, MA, (2)Department of Medical Genetics, Turgut Ozal University School of Medicine, Ankara, Turkey

Supercooling preservation holds the potential to drastically extend the preservation time of organs, tissues and engineered tissue products, and fragile cell types that do not lend themselves well to cryopreservation or vitrification. We investigate the effects of supercooling preservation (SCP at -4 oC) on primary rat hepatocytes stored in cryovials and compare its success to that of static cold storage (CS at +4 oC) and cryopreservation. We consider two  preservation solutions a) Hypothermosol (HTS-FRS) and b) University of Wisconsin Solution (UW) and a range of preservation temperatures (-4 to -10 oC). We find that there exists an optimum temperature (-4 oC) for SCP of rat hepatocytes which yields the highest viability; at this temperature HTS-FRS significantly outperforms UW solution in terms of viability and functional characteristics (secretions and enzymatic activity in suspension and plate culture). With the HTS-FRS solution we show that the cells can be stored for up to a week with high viability (~56 %); moreover we also show that the preservation can be performed in large batches (50 million cells) with equal or better viability and no loss of functionality as compared to smaller batches (1.5 million cells) performed in cryovials.

Extended Abstract: File Not Uploaded
See more of this Session: Poster Session: Bioengineering
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division